UNIV BORDEAUX SEGALEN has a total of 29 patent applications. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are HAYDEN MICHAEL R, BIOALLIANCE PHARMA SA and INDEVUS PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Canada | 5 | |
#4 | France | 4 | |
#5 | South Africa | 2 | |
#6 | African Regional Industrial Property Organization | 1 | |
#7 | Australia | 1 | |
#8 | Brazil | 1 | |
#9 | Colombia | 1 | |
#10 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Measurement | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Measuring microorganism processes | |
#5 | Enzymes | |
#6 | Peptides | |
#7 | Diagnosis and surgery | |
#8 | Foods | |
#9 | Analysing materials | |
#10 | Measuring electric variables |
# | Name | Total Patents |
---|---|---|
#1 | Baltz Theo | 7 |
#2 | Coustou Linares Virginie | 6 |
#3 | Plazolles Nicolas | 4 |
#4 | Taieb Alain | 4 |
#5 | Thonnus Magali | 3 |
#6 | Aurias Alain | 3 |
#7 | Coindre Jean-Michel | 3 |
#8 | Chibon Frederic | 3 |
#9 | Legembre Patrick | 2 |
#10 | Denis De Senneville Baudouin | 2 |
Publication | Filing date | Title |
---|---|---|
WO2014106649A1 | Selective nox-1 inhibitor peptides and uses thereof | |
FR3002453A1 | NOVEL COMBINATIONS COMPRISING A POLYPHENOLIC EXTRACT FROM GRAPE MARC WITH AN ANTIHYPERTENESS AND USES THEREOF | |
WO2013110902A1 | Hydrogel-based decontamination of aqueous samples containing nanoparticles | |
WO2013034746A1 | Anti-inflammatory compositions comprising malvidin - 3 - o - beta-glucoside and a propolis extract | |
WO2013017770A1 | Device for culturing nerve cells, and uses thereof | |
WO2012163982A1 | Method for targeting a region of interest of biological tissue of a patient, and related device | |
EP2502932A1 | Novel beta-oxidation pathway and hemicascomycetes yeast mutants | |
AP201206303A0 | Anti-trypanosomiasis vaccines and diagnostics. | |
CA2780208A1 | Therapeutic and diagnostic applications against trypanosomosis | |
CA2767479A1 | Use of xenon for treating hypersensitivity to pain | |
BRPI1016064A2 | "multi-compartment formulation, process for preparing same, carriers or vectoring agents, and intracellular release of therapeutic agents, use of a formulation, and pharmaceutical composition" |